Paul Medeiros
Directeur Général chez Q-State Biosciences, Inc.
Profil
Paul Medeiros is currently the Chief Executive Officer & Director at Q-State Biosciences, Inc. He is also a Member at The American Marketing Association, Licensing Executives Society, and Chief Operating Officer at New England Dental Partners.
Previously, he worked as a Director at Kolltan Pharmaceuticals, Inc. and as a Vice President at Schering-Plough Corp.
from 2005 to 2009.
From 2009 to 2011, he served as the Chief Business Officer & SVP-Business Development at Sarepta Therapeutics, Inc. He was also the President at Imbrium Therapeutics LP from 2019 to 2020.
Mr. Medeiros completed his undergraduate degree at Brown University and holds an MBA from Columbia Business School.
Postes actifs de Paul Medeiros
| Sociétés | Poste | Début |
|---|---|---|
| Licensing Executives Society | Corporate Officer/Principal | 13/06/2009 |
The American Marketing Association
 The American Marketing Association Miscellaneous Commercial ServicesCommercial Services The American Marketing Association operates professional associations for marketers. The company offers services to marketing professionals including best practices and research studies, job resources, publications and directories. Its publications include flagship semi-monthly magazine Marketing News, as well as journal of marketing, journal of public policy and marketing and a variety of newsletters. The company was founded in 1931 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 13/06/2009 |
Q-State Biosciences, Inc.
 Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Directeur Général | 05/10/2020 |
New England Dental Partners
 New England Dental Partners Medical/Nursing ServicesHealth Services New England Dental Partners provides dental support services. The company is based in Bourne, MA. Nicholas T. Papapetros has been the CEO of the company since 2019. | Directeur des opérations | - |
Anciens postes connus de Paul Medeiros
| Sociétés | Poste | Fin |
|---|---|---|
Imbrium Therapeutics LP
 Imbrium Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Imbrium Therapeutics LP is a clinical-stage biopharmaceutical company based in Stamford, CT. The company is dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. Imbrium is pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. The company strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians, and health systems worldwide. Imbrium has built a robust and diversified pipeline of investigational drug candidates, and actively collaborates with industry and academic partners to identify and advance future impactful medicines. | President | 01/09/2020 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2011 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Directeur/Membre du Conseil | - |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | - |
Formation de Paul Medeiros
| Brown University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
| Licensing Executives Society | |
The American Marketing Association
The American Marketing Association Miscellaneous Commercial ServicesCommercial Services The American Marketing Association operates professional associations for marketers. The company offers services to marketing professionals including best practices and research studies, job resources, publications and directories. Its publications include flagship semi-monthly magazine Marketing News, as well as journal of marketing, journal of public policy and marketing and a variety of newsletters. The company was founded in 1931 and is headquartered in Chicago, IL. | Commercial Services |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Health Technology |
Imbrium Therapeutics LP
Imbrium Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of Purdue Pharma LP, Imbrium Therapeutics LP is a clinical-stage biopharmaceutical company based in Stamford, CT. The company is dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. Imbrium is pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. The company strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians, and health systems worldwide. Imbrium has built a robust and diversified pipeline of investigational drug candidates, and actively collaborates with industry and academic partners to identify and advance future impactful medicines. | Health Technology |
New England Dental Partners
New England Dental Partners Medical/Nursing ServicesHealth Services New England Dental Partners provides dental support services. The company is based in Bourne, MA. Nicholas T. Papapetros has been the CEO of the company since 2019. | Health Services |
